Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ISPCNASDAQ:IVFNASDAQ:NIVFOTCMKTS:ZICX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeISPCiSpecimen$1.02+2.0%$1.12$0.86▼$11.80$2.47M1.61382,200 shs56,054 shsIVFINVO Fertility$0.86-1.3%$0.00$0.82▼$17.04$1.87M2.04564,780 shs54,365 shsNIVFNewGenIvf Group$0.93-5.8%$2.24$0.85▼$656.00$4.00M-0.031.03 million shs746,741 shsZICXZicix$0.00$0.00$0.00▼$0.00$550K1.7859,618 shsN/AThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceISPCiSpecimen0.00%+8.67%-19.05%-10.53%+277.08%IVFINVO Fertility0.00%-5.86%-42.01%+86,399,900.00%+86,399,900.00%NIVFNewGenIvf Group0.00%-9.42%-59.43%-79.43%-99.52%ZICXZicix0.00%0.00%0.00%+50.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationISPCiSpecimen0.6462 of 5 stars0.05.00.00.00.00.80.6IVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceISPCiSpecimen 0.00N/AN/AN/AIVFINVO Fertility 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/AZICXZicix 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookISPCiSpecimen$9.29M0.27N/AN/A$1.95 per share0.52IVFINVO Fertility$6.53M0.29N/AN/A($29.86) per share-0.03NIVFNewGenIvf Group$5.43M0.74N/AN/A($29.20) per share-0.03ZICXZicixN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateISPCiSpecimen-$12.50M-$12.89N/A∞N/A-139.63%-285.20%-114.37%N/AIVFINVO Fertility-$9.10M-$34.06N/A∞N/A-377.73%N/A-88.18%N/ANIVFNewGenIvf Group-$520KN/A0.00∞N/AN/AN/AN/AN/AZICXZicixN/AN/A0.00∞N/AN/AN/AN/AN/ALatest ZICX, ISPC, IVF, and NIVF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025IVFINVO FertilityN/A-$12.53N/A-$12.53N/A$1.64 million5/19/2025Q1 2025ISPCiSpecimenN/A-$0.71N/A-$0.71N/A$1.06 million4/14/2025Q4 2024ISPCiSpecimen-$4.00-$6.28-$2.28-$6.28$2.98 million$1.48 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthISPCiSpecimenN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AZICXZicixN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioISPCiSpecimenN/A0.310.31IVFINVO FertilityN/A0.080.07NIVFNewGenIvf GroupN/A1.171.14ZICXZicixN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipISPCiSpecimen13.62%IVFINVO Fertility12.02%NIVFNewGenIvf Group66.24%ZICXZicixN/AInsider OwnershipCompanyInsider OwnershipISPCiSpecimen12.20%IVFINVO Fertility0.57%NIVFNewGenIvf Group31.80%ZICXZicixN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableISPCiSpecimen602.50 million2.19 millionNot OptionableIVFINVO Fertility102.16 million2.15 millionN/ANIVFNewGenIvf GroupN/A4.33 million2.95 millionN/AZICXZicix2916.02 millionN/ANot OptionableZICX, ISPC, IVF, and NIVF HeadlinesRecent News About These CompaniesWhat to buy and skip during Amazon’s Prime Big Deal Days, according to expertsOctober 8, 2023 | nbcnews.comBest art supplies stores to shop online in the UKSeptember 22, 2023 | standard.co.ukSZicix Corporation (ZICX) Stock Historical Prices & Data - Yahoo FinanceSeptember 8, 2023 | finance.yahoo.com10 best die cutting machines for craft aficionadosAugust 31, 2023 | msn.comZICIX+CTIP-FII RECEIVES NOTICE TO PROCEED FROM PROJECT OWNER TO START THE $20 MILLION SENIOR CITIZENS RESIDENCE PROJECT IN NEWARK, NEW JERSEYMarch 6, 2023 | finance.yahoo.comZICIX AND ASIA BASED CONSTRUCTION GROUP AGREES TO FORM A CONSTRUCTION MANAGEMENT COMPANYNovember 28, 2022 | finance.yahoo.comZICIX + CTIP-FII RECEIVES ORDER FROM CITY OF KAKATA, LIBERIA TO BUY PASSENGER BUSESOctober 17, 2022 | finance.yahoo.comZICIX+CTIP-FII UPDATES STOCKHOLDERS ON PROJECTS ON-GOINGSeptember 6, 2022 | finance.yahoo.comZICIX owned CTIP-FII Receives Award from Liberia...August 24, 2022 | benzinga.comZICIX owned CTIP-FII Receives Award from Liberia's Ministry of Public Works for Road ProjectAugust 22, 2022 | tmcnet.comZICIX owned CTIP-FII Receives Award from Liberia’s Ministry of Public Works for Road ProjectAugust 22, 2022 | finance.yahoo.comZICIX Receives Health Ministry's Support for Hospital Project in SenegalAugust 13, 2022 | stockhouse.comZICIX OPERATING COMPANY SIGNS DEVELOPMENT CONTRACT TO BUILD HOSPITALSAugust 12, 2022 | finance.yahoo.comZICIX Finalizes Acquisition of CTIP-FIIAugust 12, 2022 | finance.yahoo.comZICIX AND CTIP-FII JOINS DEVELOPMENT OF P2A HOSPITAL PROJECT IN SENEGALAugust 12, 2022 | finance.yahoo.comZICIX Corporation to Develop P2A Hospital Project in SenegalAugust 12, 2022 | finance.yahoo.comZICIX Receives Health Ministry’s Support for Hospital Project in SenegalAugust 12, 2022 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeZICX, ISPC, IVF, and NIVF Company DescriptionsiSpecimen NASDAQ:ISPC$1.02 +0.02 (+2.00%) Closing price 07/3/2025 03:45 PM EasternExtended Trading$1.00 -0.02 (-1.86%) As of 07/3/2025 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.INVO Fertility NASDAQ:IVF$0.86 -0.01 (-1.31%) As of 07/3/2025 12:54 PM EasternNAYA Biosciences (NASDAQ: NAYA) is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and fertility. Our hub & spoke model harnesses the shared resources of a parent company and agility of lean strategic franchises, enabling efficient acquisition, development, and partnering of assets as well as optimized return on investment by combining the upside of innovative clinical-stage therapeutics with scalable, profitable commercial revenues. NAYA’s expanding portfolio of assets currently includes NY-303, a GPC3 and NKp46 targeting bispecific antibody for the treatment of hepatocellular carcinoma (HCC) with a unique mode of action targeting non-responders to the current immunotherapy standard of care (approximately 70% of the current treatable market) cleared to enroll patients in a Phase I/II monotherapy trial in early 2025, NY-338, a CD38 and NKp46 targeting bispecific antibody for the treatment of multiple myeloma and autoimmune diseases with a differentiated safety and efficacy profile, and INVOcell®, an FDA-approved fertility device which has demonstrated comparable success rates to traditional In Vitro Fertilization (IVF).NewGenIvf Group NASDAQ:NIVF$0.93 -0.06 (-5.76%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$0.91 -0.02 (-2.57%) As of 07/3/2025 04:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.Zicix OTCMKTS:ZICX$0.0006 0.00 (0.00%) As of 07/3/2025Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress testing, carotid ultrasound, and halter and event monitoring services; medical services, such as general medical care, medical care for home health patients, general and immigration physicals, weight reduction, cold laser pain relief treatment, physical therapy, and anti-aging treatment; and MRI, CT, and X-Ray services. The company was formerly known as Bederra Corporation and changed its name to Zicix Corporation on February 8, 2011. Zicix Corporation was founded in 1979 and is based in Houston, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
